PharmaStem Therapeutics Overview
- Year Founded
-
1985
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
PharmaStem Therapeutics General Information
Description
Provider of research and development services intended for stem cell preservation. The company specializes in the study of the development of umbilical cord and placental blood preservation for the treatment of cancers, immune-specific diseases, and gene therapy, enabling patients to get the required medical assistance.
Contact Information
Website
www.pharmastem.comCorporate Office
- 69 Prospect Avenue
- Larchmont, NY 10538
- United States
Corporate Office
- 69 Prospect Avenue
- Larchmont, NY 10538
- United States
PharmaStem Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 25-Apr-2025 | Completed | Out of Business | |||
| 2. Secondary Transaction - Private | 29-Jul-2024 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Generating Revenue |
PharmaStem Therapeutics Comparisons
Industry
Financing
Details
PharmaStem Therapeutics Competitors (6)
One of PharmaStem Therapeutics’s 6 competitors is Mesoblast, a Corporation company based in Melbourne, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mesoblast | Corporation | Melbourne, Australia | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ | ||||
| Brainstorm Cell Therapeutics | Corporation | New York, NY | ||||
| Genecell International | Corporation | Miami, FL | ||||
| Cerenome | Corporation | Houston, TX |
PharmaStem Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PharmaStem Therapeutics Patents
PharmaStem Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6569427-B1 | Administering a cryoprotective agent and stem cells to provide hematopoietic reconstitution | Inactive | 12-Nov-1987 | ||
| US-5004681-A | Anemia, malignancies, aids, immumology dysfunctions | Inactive | 12-Nov-1987 | ||
| US-5192553-A | Cryogenics | Inactive | 12-Nov-1987 | ||
| US-6461645-B1 | Cryopreserved pharmaceutical composition comprising viable human neonatal or fetal hematopoietic stem cells derived from umbilical cord or placental blood of single human collected at birth, cryopreservative, carrier | Inactive | 12-Nov-1987 | ||
| US-6605275-B1 | Growing in vitro human neonatal or fetal hematopoietic stem cells from umbilical cord or placental blood collected at birth, introducing into human patient effective amount of progeny stem cells for hematopoietic reconstitution | Inactive | 12-Nov-1987 | C12N5/0647 |
PharmaStem Therapeutics FAQs
-
When was PharmaStem Therapeutics founded?
PharmaStem Therapeutics was founded in 1985.
-
Where is PharmaStem Therapeutics headquartered?
PharmaStem Therapeutics is headquartered in Larchmont, NY.
-
What industry is PharmaStem Therapeutics in?
PharmaStem Therapeutics’s primary industry is Biotechnology.
-
Is PharmaStem Therapeutics a private or public company?
PharmaStem Therapeutics is a Private company.
-
What is PharmaStem Therapeutics’s current revenue?
The current revenue for PharmaStem Therapeutics is .
-
Who are PharmaStem Therapeutics’s competitors?
Mesoblast, Lisata Therapeutics, Brainstorm Cell Therapeutics, Genecell International, and Cerenome are some of the 6 competitors of PharmaStem Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
